**BioAgilytix Expands Durham Operations with $20M Investment**
BioAgilytix, a leading bioanalytical laboratory supporting pharmaceutical and biotechnology companies in drug development, is expanding its operations in Durham, North Carolina. The company is adding a new 26,000-square-foot laboratory space to complement its existing facilities and further enhance its capabilities.
This expansion marks another step in BioAgilytix’s continued growth in the region. The company recently completed a 76,000-square-foot facility on South Miami Boulevard, which supplements its 87,000-square-foot headquarters located at 2300 Dglert Drive.
The new $20 million facility will provide enhanced capacity for chemistry, manufacturing, and controls (CMC) services. BioAgilytix has begun staffing the new space and installing equipment, a process expected to span the next two to three years.
The expansion is being financed internally by the company. BioAgilytix is part of the portfolio owned by private equity firm Cinven, which acquired a majority stake in the company in December 2021.
